MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 110 filers reported holding MEI PHARMA INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $0 | -100.0% | 832 | -86.1% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 5,995 | +56.4% | 0.00% | – |
| Q3 2022 | $1,000 | -99.0% | 3,832 | -97.7% | 0.00% | – |
| Q2 2022 | $102,000 | +161.5% | 167,282 | +162.2% | 0.00% | – |
| Q1 2022 | $39,000 | -86.7% | 63,802 | -42.2% | 0.00% | – |
| Q4 2021 | $294,000 | +131.5% | 110,308 | +139.7% | 0.00% | – |
| Q3 2021 | $127,000 | -55.1% | 46,020 | -53.5% | 0.00% | – |
| Q2 2021 | $283,000 | +82.6% | 98,873 | +118.9% | 0.00% | – |
| Q1 2021 | $155,000 | +12.3% | 45,171 | -13.4% | 0.00% | – |
| Q4 2020 | $138,000 | -4.2% | 52,187 | +14.0% | 0.00% | – |
| Q3 2020 | $144,000 | -55.1% | 45,781 | -41.1% | 0.00% | – |
| Q2 2020 | $321,000 | -10.1% | 77,702 | -65.0% | 0.00% | – |
| Q1 2020 | $357,000 | -48.2% | 222,092 | -20.1% | 0.00% | – |
| Q4 2019 | $689,000 | +90.9% | 277,865 | +29.6% | 0.00% | – |
| Q3 2019 | $361,000 | -46.4% | 214,458 | -20.2% | 0.00% | – |
| Q2 2019 | $674,000 | +4.0% | 268,702 | +27.2% | 0.00% | – |
| Q1 2019 | $648,000 | +33.1% | 211,201 | +14.5% | 0.00% | – |
| Q4 2018 | $487,000 | -49.9% | 184,504 | -18.3% | 0.00% | – |
| Q3 2018 | $973,000 | -32.7% | 225,696 | -38.5% | 0.00% | – |
| Q2 2018 | $1,445,000 | +1167.5% | 366,819 | +772.2% | 0.00% | – |
| Q3 2017 | $114,000 | -29.6% | 42,058 | -38.0% | 0.00% | – |
| Q2 2017 | $162,000 | +3950.0% | 67,825 | +2508.7% | 0.00% | – |
| Q1 2017 | $4,000 | -94.8% | 2,600 | -94.0% | 0.00% | – |
| Q1 2015 | $77,000 | -97.6% | 43,356 | -94.3% | 0.00% | -100.0% |
| Q4 2014 | $3,231,000 | -65.3% | 756,827 | -43.9% | 0.00% | -50.0% |
| Q3 2014 | $9,302,000 | +1.5% | 1,348,095 | -6.8% | 0.00% | 0.0% |
| Q2 2014 | $9,169,000 | -31.4% | 1,446,243 | +20.4% | 0.00% | -50.0% |
| Q1 2014 | $13,367,000 | +141.0% | 1,200,944 | +73.4% | 0.00% | +100.0% |
| Q4 2013 | $5,546,000 | +616.5% | 692,393 | +537.6% | 0.00% | – |
| Q2 2013 | $774,000 | – | 108,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|